Feasibility and safety profile of high-dose oxaliplatin-based PIPAC (120mg/m2) in the treatment of advanced peritoneal metastatic disease: MINOS real-life multicenter study

20260 citationsJournal Articlehybrid Open Access

Authors

Diego A. Zambrano · Universidad de Especialidades Espíritu Santo

Alexandru Lintis · Hôpital Lyon Sud

Amaniel Kefleyesus · University Hospital of Lausanne

Abdelkader Taibi · Centre Hospitalier Universitaire de Limoges

Clarisse Eveno · Centre Hospitalier Universitaire de Lille

M Pocard · Sorbonne Université

Guillaume De Meeus

Abstract

High-dose PIPAC-Ox is feasible and safe. Local and histological response are well identified. However abdominal pain remains a main concern and continuous IV protocols should be considered routinely.

Topics & Keywords

Intraperitoneal and Appendiceal Malignancies Nanoplatforms for cancer theranostics Adrenal and Paraganglionic Tumors

Publication Details

Published in: European Journal of Surgical Oncology

Volume 52, Issue 5, pp. 111731-111731

DOI: 10.1016/j.ejso.2026.111731

Field-Weighted Citation Impact: 0.00

Command Palette

Feasibility and safety profile of high-dose oxaliplatin-based PIPAC (120mg/m2) in the treatment of advanced peritoneal metastatic disease: MINOS real-life multicenter study

Authors

Abstract

Topics & Keywords

Publication Details